EU Updates Guidance On Safety Features For Drugs Under Falsified Medicines Directive
Executive Summary
The EU has issued updated guidance on the Falsified Medicines Directive, which gives drug manufacturers until February 2019 to affix 2D barcodes on their products to allow the identification and authentication of individual packs.
You may also be interested in...
European Commission Names Drugs That Won't Need EU 'Safety Feature'
The European Commission has set out the fine detail of the "unique identifier" that in future will have to be affixed to the packaging of practically all prescription medicines marketed in Europe, as required by the EU's directive on falsified medicines1.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.